Sort
82,697 grants matching “vaccine development”
DEVELOPMENT OF TUBERCULOSIS VACCINE FORMULATIONS
$2,748,153Chris Fox · Access To Advanced Health Institute · N01 · FY2017 · AI
Pre-clinical Vaccine Development for Respiratory Viruses
$2,748,001John Mascola · National Institute Of Allergy And Infectious Diseases · ZIC · FY2020 · AI
NCI-Frederick Support and Technical Services
$2,747,915John Niederhuber · Office Of The Director, Nci · ZIC · FY2009 · CA
Clinical Trials of Parainfluenza and Respiratory Syncytial Virus Vaccines
$2,747,716Peter Leon Collins · National Institute Of Allergy And Infectious Diseases · ZIA · FY2011 · AI
Indiana University Melvin and Bren Simon Cancer Center Support Grant
$2,746,580Kelvin P Lee · Indiana University Indianapolis · P30 · FY2021 · CA
Indiana University Melvin and Bren Simon Cancer Center Support Grant
$2,746,580Kelvin P Lee · Indiana University Indianapolis · P30 · FY2020 · CA
Indiana University Melvin and Bren Simon Cancer Center Support Grant
$2,746,580Kelvin P Lee · Indiana University Indianapolis · P30 · FY2022 · CA
Indiana University Melvin and Bren Simon Cancer Center Support Grant
$2,746,580Kelvin P Lee · Indiana University Indianapolis · P30 · FY2023 · CA
Bone Marrow Grafting and Cellular Therapy for Leukemia and Lymphoma
$2,745,884Robert S Negrin · Stanford University · P01 · FY2019 · CA
The Role of Inflammasome Signaling in Tauopathies
$2,745,818Kiran Bhaskar · University Of New Mexico Health Scis Ctr · RF1 · FY2020 · NS
Immune Responses to Malaria and HIV Infection and Immunization
$2,742,800Kenneth D Stuart · Seattle Biomedical Research Institute · U19 · FY2017 · AI
Immunologic evaluation of HIV-1 HVTN experimental medicine trials HVTN 307, HVTN 309 and HVTN312
$2,741,630Barton F Haynes · Duke University · UM1 · FY2024 · AI
Antigen-specific T-cell Activation, Application to Vaccines for Cancer and AIDS
$2,741,261Jay A Berzofsky · Division Of Clinical Sciences - Nci · ZIA · FY2009 · CA
HIV-1 VACCINE CANDIDATES DELIVERED BY VSV VECTORS
$2,740,852John Eldridge · Profectus Biosciences, Inc. · N01 · FY2010 · AI
NIDA Clinical Trials Network: Greater New York Node
$2,740,413John P Rotrosen · New York University School Of Medicine · UG1 · FY2019 · DA
Immune Modulation After Allogeneic HCT
$2,740,234Robert Jon Soiffer · Dana-Farber Cancer Inst · P01 · FY2020 · CA
Development of Technologies to Facilitate the Use of and Response to Vaccines
$2,739,889Laurence Lemiale · Emergent Product Development Gaithersbur · N01 · FY2020 · AI
Immune Modulation After Allogeneic HCT
$2,739,426Robert Jon Soiffer · Dana-Farber Cancer Inst · P01 · FY2021 · CA
Bone Marrow Grafting and Cellular Therapy for Leukemia and Lymphoma
$2,739,423Robert S Negrin · Stanford University · P01 · FY2020 · CA
WEILL CORNELL PROGRAM OF EXCELLENCE IN GENE THERAPY
$2,739,199Weill Medical College Of Cornell Univ · U01 · FY2001 · HL
WEILL CORNELL PROGRAM OF EXCELLENCE IN GENE THERAPY
$2,739,199Weill Medical College Of Cornell Univ · U01 · FY2004 · HL
Task A25: Development of Rat Animal Model
$2,738,715Rick Lyons · University Of New Mexico Health Scis Ctr · N01 · FY2011 · AI
Emerging Infectious Diseases Research Centers Coordination Center (EIDRC CC)
$2,738,672Gregory D Sempowski · Research Triangle Institute · U01 · FY2024 · AI
Spore in Head and Neck Cancer
$2,737,829David Sidransky · Johns Hopkins University · P50 · FY2016 · DE
UCLA AIDS Prevention and Treatment Clinical Trials Unit
$2,737,442Judith S. Currier · University Of California Los Angeles · UM1 · FY2014 · AI